Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 2:23 PM
Ignite Modification Date: 2025-12-25 @ 12:59 PM
NCT ID: NCT02785159
Description: Adverse events were collected from participants who were randomized, received at least 1 confirmed dose of study drug, and had at least 1 post-Baseline safety assessment (Safety Population).
Frequency Threshold: 5
Time Frame: 12 weeks
Study: NCT02785159
Study Brief: Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
IDP-118 Lotion Lotion IDP-118 Lotion: Lotion None None 1 60 10 60 View
Tazorac Cream Cream Tazorac Cream: Cream None None 1 57 8 57 View
IDP 118 Vehicle Lotion Lotion IDP-118 Vehicle Lotion: Lotion None None 0 15 4 15 View
IDP-118 Vehicle Cream Cream IDP-118 Vehicle Cream: Cream None None 0 16 0 16 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Chest pain NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (18.0) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Skin atrophy NON_SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (18.0) View
Application site pain NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (18.0) View
Application site pruritis NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (18.0) View
Dermatitis contact NON_SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (18.0) View